A Comprehensive Review of Pathophysiological Link Between Non-alcoholic Fatty Liver Disease, Insulin Resistance, and Metabolic Syndrome.
Level 5 - mechanism / opinion, no new human data
Narrative review detailing pathophysiological mechanisms without systematic search methodology or original clinical data.
PubMed 39807459 · doi:10.7759/cureus.75677
What was done
This is a narrative review examining the literature on molecular mechanisms connecting non-alcoholic fatty liver disease (NAFLD), insulin resistance (IR), and metabolic syndrome (MetS), with attention to the gut-liver axis and potential therapeutic targets.
What was found
The abstract reports purely qualitative mechanistic concepts and no numerical data. It notes that insulin resistance drives hepatic lipid accumulation via increased peripheral lipolysis, elevated free fatty acid flux, and impaired fatty acid oxidation, while metabolic syndrome components and gut-liver axis dysbiosis/intestinal permeability further amplify chronic inflammation and metabolic dysfunction.
Why it matters
It outlines how insulin resistance and systemic metabolic dysfunction act as bidirectional drivers of NAFLD progression, underscoring the need for multi-pathway therapeutic interventions.
Limits
The abstract describes a non-systematic narrative review without defined search parameters, quality appraisal of included studies, sample sizes, or quantitative meta-analytic findings.
Cited by
- context There are at least 31 distinct diseases causally or pathophysiologically connected to insulin resistance.